Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantus vs Intermediate Insulin in Adolescents with T1DM
NCT00046501Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2002
- Primary completion
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Nov 2002; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00046501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046501.